Remedent, Inc. (REMI)
- Previous Close
0.0000 - Open
0.0550 - Bid 0.0500 x --
- Ask 0.0550 x --
- Day's Range
0.0500 - 0.0550 - 52 Week Range
0.0200 - 0.1500 - Volume
19,000 - Avg. Volume
936 - Market Cap (intraday)
999,800 - Beta (5Y Monthly) -0.01
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.
www.remedent.comRecent News: REMI
View MorePerformance Overview: REMI
Trailing total returns as of 11/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: REMI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: REMI
View MoreValuation Measures
Market Cap
999.80k
Enterprise Value
999.80k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-3.80%
Return on Equity (ttm)
-9.96%
Revenue (ttm)
46.11k
Net Income Avi to Common (ttm)
-304.13k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.55k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--